Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Course, Outcomes and Risk Factors of Myocarditis and Pericarditis Following Administration of mRNA- 1273 (ELASOMERAN)

NCT06113692 is registered in ClinicalTrials.gov with ModernaTX, Inc. as lead sponsor.

NCT NCT06113692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06113692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Course, Outcomes and Risk Factors of Myocarditis and Pericarditis Following Administration of mRNA- 1273 (ELASOMERAN)
Lead sponsor
ModernaTX, Inc.
Phase
Observational
Overall status
Completed
Start date
March 31, 2023
Completion date
June 30, 2025
Enrollment
1,169 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

myocarditis, pericarditis